References
- Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, Kampmann B, et al. Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and metaanalysis. Eur Respir J 2011;37: 88–99.
- Diel R, Loddenkemper R, Niemann S, Meywald-Walter K, Nienhaus A. Negative and positive predictive value of a whole-blood interferon-{gamma} release assay for developing active tuberculosis: an update. Am J Respir Crit Care Med 2011;183:88–95.
- Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008;149:177–84.
- Pai M. Spectrum of latent tuberculosis – existing tests cannot resolve the underlying phenotypes. Nat Rev Microbiol 2010;8:242.
- Hougardy JM, Schepers K, Place S, Drowart A, Lechevin V, Verscheure V, et al. Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis. PloS One 2007;2:e926.
- Corbière V, Pottier G, Bonkain F, Schepers K, Verscheure V, Lecher S, et al. Risk stratification of latent tuberculosis defined by combined interferon gamma release assays. PloS One 2012;7:e43285.
- Delogu G, Chiacchio T, Vanini V, Butera O, Cuzzi G, Bua A, et al. Methylated HBHA produced in Mycobacterium smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders. PLoS One 2011;6:e1815.
- Chiacchio T, Petruccioli E, Vanini V, Butera O, Cuzzi G, Petrone L, et al. Higher frequency of T-cell response to Mycobacterium tuberculosis latency antigen Rv2628 at the site of active tuberculosis disease than in peripheral blood. PLoS One 2011;6:e27539.
- Sargentini V, Mariotti S, Carrara S, Gagliardi MC, Teloni R, Goletti D, et al. Cytometric detection of antigen-specific IFNgamma/IL-2 secreting cells in the diagnosis of tuberculosis. BMC Infect Dis 2009;9:99.
- Wang S, Diao N, Lu C, Wu J, Gao Y, Chen J, et al. Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population. PloS One 2012;7:e51338.
- Armand M, Chhor V, de Lauzanne A, Guérin-El Khourouj V, Pédron B, Jeljeli M, et al. Cytokine responses to quantiferon peptides in pediatric tuberculosis: a pilot study. J Infect 2013;68:62–70.
- Delogu G, Bua A, Pusceddu C, Parra M, Fadda G, Brennan MJ, et al. Expression and purification of recombinant methylated HBHA in Mycobacterium smegmatis. FEMS Microbiol Lett 2004;239:33–9.
- Goletti D, Raja A, Ahamed Kabeer BS, Rodrigues C, Sodha A, Butera O, et al. IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis. J Infect 2010;61:133–43.
- Molicotti P, Bua A, Cubeddu M, Cannas S, Delogu G, Zanetti S. Tuberculosis patients are characterized by a low-IFN-gamma high-TNF-alfa response to methylated HBHA produced in Mycobacterium smegmatis. Diagn Microbiol Infect Dis 2011;71:449–52.
- Dessein R, Corbière V, Nortier J, Dratwa M, Gastaldello K, Pozdzik A, et al. Heparin-binding haemagglutinin, a new tool for the detection of latent Mycobacterium tuberculosis infection in hemodialysis patients. PLoS One 2013;8: e71088.